Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis

British Journal of Neurosurgery

Volumn 23, Issue 2, 2009, Pages 170-178

  Molenaar, Richard ^a   Wiggenraad, Ruud ^a   Verbeek De Kanter, Antoinette ^a   Walchenbach, Rob ^a   Vecht, Charles ^a  

^a Medical Center the Hague   (Netherlands)

Author keywords

Brain metastasis; Metastasis; Stereotactic radiosurgery; Stereotaxy

Indexed keywords

DEXAMETHASONE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION NECROSIS; STEREOTACTIC RADIOSURGERY; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIATION TOLERANCE; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 67651172865     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690902755613     Document Type: Article

References (50)

1. Smith ML, Lee JY. Stereotactic radiosurgery in the management of brain metastasis. Neurosurg Focus 2007;22:E3:1-8.
2. Pollock BE, Brown PD, Foote RL, Stafford SL, Schomberg PJ. Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol 2003;61:73-80.
3. Kanner AA, Suh JH, Siomin VE, Lee SY, Barnett GH, Vogelbaum MA. Posterior fossa metastases: aggressive treatment improves survival. Stereotact Funct Neurosurg 2003;81:18- 23.
4. Kaal EC, Niel CG, Vecht CJ. Therapeutic management of brain metastasis. Lancet Neurol 2005;5:289-98.
5. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
6. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993;33:583-90.
7. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
8. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990 Jul;8(7):1277-80.
9. Joseph J, Adler JR, Cox RS, Hancock SL. Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival. J Clin Oncol 1996; 14:1085-92.
10. Chidel MA, Suh JH, Reddy CA, Chao ST, Lundbeck MF, Barnett GH. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 2000;47:993-9.
11. Becker G, Jeremic B, Engel C, et al. Radiosurgery for brain metastases: the Tuebingen experience. Radiother Oncol 2002;62:233-7.
12. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-72.
13. McDermott MW, Sneed PK. Radiosurgery in metastatic brain cancer. Neurosurgery 2005;57:Suppl:45-53.
14. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6:1-9.
15. Maor MH, Frias AE, Oswald MJ. Palliative radiotherapy for brain metastases in renal carcinoma. Cancer 1988;62:1912-7.
16. Mahmoud-Ahmed AS, Suh JH, Lee SY, Crownover RL, Barnett GH. Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. Int J Radiat Oncol Biol Phys 2002;54:810-7.
17. Fleckenstein K, Hof H, Lohr F, Wenz F, Wannenmacher M. Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution. Strahlenther Onkol 2004;180:268-73.
18. Alexander E, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995;87:34-40.
19. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008;70:510-14.
20. Shirato H, Takamura A, Tomita M, et al. Stereotactic irradiation without whole-brain irradiation for single brain metastasis. Int J Radiat Oncol Biol Phys 1997;37:385-91.
21. Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metas-tases. J Clin Oncol 1998;16:3563-9.
22. Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 1999;43:549-58.
23. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005;62:1125-32.
24. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-91.
25. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789-96.
26. Swennen MH, Bromberg JE, Witkamp TD, Terhaard CH, Postma TJ, Taphoorn MJ. Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma. J Neurooncol 2004;66:333-9.
27. Loeffler JS, Kooy HM, Wen PY, et al. The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 1990;8:576-82.
28. Noel G, Proudhom MA, Valery CA, et al. Radiosurgery for reirradiation of brain metastasis: results in 54 patients. Radiother Oncol 2001;60:61-7.
29. Sheehan J, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg 2005;102:Suppl:247-54.
30. Kwon KY, Kong DS, Lee JI, Nam DH, Park K, Kim JH. Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg 2007;109:132-7.
31. Matsuo T, Shibata S, Yasunaga A, et al. Dose optimization and indication of Linac radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 1999;45:931-9.
32. Nieder C, Nestle U, Walter K, Niewald M, Schnabel K. Dose-response relationships for radiotherapy of brain metastases: role of intermediate-dose stereotactic plus whole-brain radiotherapy. Am J Clin Oncol 2000;23:584-8.
33. Shiau CY, Sneed PK, Shu HK, et al. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 1997;37: 375-83.
34. Jawahar A, Shaya M, Campbell P, et al. Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases. Surg Neurol 2005 Sep;64:207-12.
35. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000;47:291-8.
36. Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH. Local control of brain metastases by stereotactic radio-surgery in relation to dose to the tumor margin. J Neurosurg 2006;104:907-12.
37. Tokuuye K, Akine Y, Sumi M, et al. Reirradiation of brain and skull base tumors with fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1998;40: 1151-5.
38. Manning MA, Cardinale RM, Benedict SH, et al. Hypofrac-tionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys 2000;47:603-8.
39. Lindvall P, Bergstrom P, Lofroth PO, Henriksson R, Bergenheim AT. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys 2005;61:1460-6.
40. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radio-ther Oncol 2006;81:18-24.
41. Narayana A, Chang J, Yenice K, et al. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases. Stereotact Funct Neurosurg 2007;85:82-7.
42. Davey P, Schwartz ML, Scora D, Gardner S, O'Brien PF. Fractionated (split dose) radiosurgery in patients with recurrent brain metastasis: implications for survival. Br J Neurosurg 2007;21:491-5.
43. Flickinger JC, Kondziolka D, Lunsford LD, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994; 28:797-802.
44. Kim YS, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain. Cancer 1997;80: 2075-83.
45. Linzer D, Ling SM, Villalobos H, et al. Gamma knife radiosurgery for large volume brain tumors: an analysis of acute and chronic toxicity. Stereotact Funct Neurosurg 1998;70:Suppl:11-18.
46. Chin LS, Ma L, DiBiase S. Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 2001;94:899-904.
47. Valery CA, Cornu P, Noel G, et al. Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg 2003;81:115-9.
48. Leber KA, Eder HG, Kovac H, Anegg U, Pendl G. Treatment of cerebral radionecrosis by hyperbaric oxygen therapy. Stereotact Funct Neurosurg 1998;70:Suppl:229-36.
49. Ohguri T, Imada H, Kohshi K, et al. Effect of prophylactic hyperbaric oxygen treatment for radiation-induced brain injury after stereotactic radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 2007;67:248-55.
50. Jagannathan J, Petit JH, Balsara K, Hudes R, Chin LS. Long-term survival after gamma knife radiosurgery for primary and metastatic brain tumors. Am J Clin Oncol 2004;27:441-4.